| Literature DB >> 35021992 |
Yuehua Li1,2,3, Junxiang Yan1,2,3, Xueqian Guo1,2,3, Xiaochen Wang1,2,3, Fenxia Liu1,2,3, Boyang Cao4,5,6.
Abstract
BACKGROUND: Vibrio cholerae, a Gram-negative bacterium, is highly motile owing to the presence of a single polar flagellum. The global anaerobiosis response regulator, ArcA regulates the expression of virulence factors and enhance biofilm formation in V. cholerae. However, the function of ArcA for the motility of V. cholerae is yet to be elucidated. CytR, which represses nucleoside uptake and catabolism, is known to play a chief role in V. cholerae pathogenesis and flagellar synthesis but the mechanism that CytR influences motility is unclear.Entities:
Keywords: ArcA; CytR; Flagellum; Motility; Vibrio cholerae
Mesh:
Substances:
Year: 2022 PMID: 35021992 PMCID: PMC8753867 DOI: 10.1186/s12866-022-02435-y
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Fig. 1ArcA represses V. cholerae motility. a. Plate showing the motility zones of the WT strain, ΔarcA mutant strain, and the complementary strain ΔarcA::ParcA in aerobic condition. b. The diameter of motility zones (mean ± SEM) for nine independent biological replicates
Fig. 2ArcA directly represses flrA expression. a. The EMSA between phosphorylated ArcA protein and the flrA promoter. The concentration of phosphorylated ArcA protein increased gradually (0 to 2.4 μM), and the amount of promoter DNA used in each reaction was 50 ng. 4.5S RNA served as the negative control. b. mRNA levels of flrA in the WT,,ΔarcA mutant strain and arcA complementary strain ΔarcA::ParcA in aerobic conditions. *, p < 0.05; **, p < 0.01; ***, p < 0.001; NS, no significance, p > 0.05. c. Expression of flrA-lux in WT strain and ΔarcA mutant strain. CPS (counts per second) values represent relative promoter-lux activities. All experiments were independently repeated at least three times. Values represent means ± SEM
Fig. 3CytR directly promotes fliK expression. a. The EMSA of CytR with the fliK promoter. The concentration of CytR protein increased gradually (0 to 3.6 μM), and the amount of promoter DNA used in each reaction was 50 ng. b. The EMSA of CRP with the fliK promoter. The concentration of CRP protein increased gradually (0 to 4 μM), and the amount of promoter DNA used in each reaction was 50 ng. The concentration of cAMP used in each reaction was 0.1 mM. c. The EMSA of CytR and CRP with the fliK promoter. The concentration of CytR and CRP protein increased gradually (0 to 3.6 or 4 μM), and the amount of promoter DNA used in each reaction was 50 ng. The concentration of cAMP used in each reaction was 0.1 mM. d. mRNA levels of fliK in the WT, ΔcytR mutant strain and the complementary strain ΔcytR::PcytR. *, p < 0.05; **, p < 0.01; ***, p < 0.001; NS, no significance, p > 0.05. e. Expression of fliK-lux in WT strain and ΔcytR mutant strain. CPS (counts per second) values represent relative promoter-lux activities. All experiments were independently repeated at least three times. Values represent means ± SEM
Fig. 4ArcA directly represses cytR expression. a. The EMSA between phosphorylated ArcA protein and the cytR promoter. The concentration of phosphorylated ArcA protein increased gradually (0 to 6 μM), and the amount of promoter DNA used in each reaction was 50 ng. b. mRNA levels of cytR in the WT, ΔarcA mutant strain and the complementary strain ΔarcA::ParcA in aerobic condition. *, p < 0.05; **, p < 0.01; ***, p < 0.001; NS, no significance, p > 0.05. c. mRNA levels of cytR in the WT, ΔarcA mutant strain and the complementary strain ΔarcA::ParcA in anaerobic condition. *, p < 0.05; **, p < 0.01; ***, p < 0.001; NS, no significance, p > 0.05. d. Expression of cytR-lux in WT strain and ΔarcA mutant strain. CPS (counts per second) values represent relative promoter-lux activities. All experiments were independently repeated at least three times, and the data shown represent comparable results. Values represent means ± SEM
Fig. 5Schematic representation of V. cholerae motility regulation network by ArcA regulating the expression of flrA directly and fliK indirectly in the manner of cytR
Bacterial strains and plasmids used in this study
| Strain or plasmid | Characteristicsa | Reference or source |
|---|---|---|
| Vibrio cholerae | ||
| El2382 | Virulent strain, O1 El Tor type, PmBr | Shanghai Municipal Center for Disease Control & Prevention |
| Δ | El2382, deletion of | This study |
| Δ | Δ | This study |
| Δ | El2382, deletion of | This study |
| Δ | Δ | This study |
| Escherichia coli | ||
| S17-1 (λpir) | [ | |
| BL21(DE3) | Host strain for protein expression | This study |
| BL21/pET28a:: | BL21(DE3) with pET28a carrying the | This study |
| BL21/pET28a:: | BL21(DE3) with pET28a carrying the | This study |
| BL21/pET28a:: | BL21(DE3) with pET28a carrying the | This study |
| Plasmids | ||
| pRE112 | pGP704 suicide plasmid, pir dependent, | [ |
| pBAD33 | arabinose inducible promoter, Cmr | [ |
| pET28a | Expression vector, Kmr | This study |
| pET28a:: | pET28a carrying the | This study |
| pET28a:: | pET28a carrying the | This study |
| pET28a:: | pET28a carrying the | This study |
| pMS402 | For construct promoter- | This study |
| | pMS402 carrying the | This study |
| | pMS402 carrying the | This study |
| | pMS402 carrying the | This study |
a r resistant. Cm, chloramphenicol, PmB, polymyxinB, Km, kanamycin
Primers used in this study
| Name | Sequence (5′–3′) | Amplifified fragment |
|---|---|---|
| Primers for construction of mutants | ||
| ∆ | GC | ∆ |
| ∆ | AAAGAAGAGGTAGCGTTACCTAAACTTGTGA | |
| ∆ | GGTAACGCTACCTCTTCTTTTATATCTAATTAG | ∆ |
| ∆ | CG | |
| ∆ | ||
| | ATGCAAACCCCGCAGATCCTT | |
| | TTAATCTTCTAAATCACCACAG | |
| ∆ | CG | ∆ |
| ∆ | GTAAAAATACCCCACCTTCGAAACCGA | |
| ∆ | CGAAGGTGGGGTATTTTTACCCTCTTTTCTCTATCG | ∆ |
| ∆ | CG | |
| ∆ | ||
| | ATGGCGACAATGAAGGATGT | |
| | AGGTGGGTTACTTCTTGCTTG | |
| Primers for identification of plasmid | ||
| pRE112-U-F | CACTGTTCGTCCATTTCCG | pRE112-UD (567) |
| pRE112-D-R | TTCGTCTCAGCCAATCCCT | |
| pRE112-U- | ||
| pRE112-U- | ||
| pBAD33-U-F | AACAAAGCGGGACCAAAG | pBAD33-UD (529) |
| pBAD33-D-R | AGAGCGTTCACCGACAAA7 | |
| pBAD33-U- | ||
| pBAD33-U- | ||
| pET28a-U-F | TAATACGACTCACTATAGGG | pET28a-UD (318) |
| pET28a-D-R | GCTAGTTATTGCTCAGCGG | |
| pET28a-U- | ||
| pET28a-U- | ||
| pET28a-U- | ||
| Primers for construction of complemented strain | ||
| | C | |
| | GG | |
| | GG | |
| | GC | |
| Primers for protein cloning | ||
| pET28a- | CG | pET28a- |
| pET28a- | CCG | |
| pET28a- | CGC | pET28a- |
| pET28a- | CCG | |
| pET28a- | CG | pET28a- |
| pET28a- | CCG | |
| Primers for bioluminescent reporter assays | ||
| pMS402- | CG | pMS402- |
| pMS402- | CCG | |
| pMS402- | CG | pMS402- |
| pMS402- | CCG | |
| pMS402- | CG | pMS402- |
| pMS402- | CCG | |
| Primers for qRT-PCR | ||
| 16S rRNA-F | GTGTACGGTGAAATGCGTAGAG | 275 bp |
| 16S rRNA-R | GCGTGGACTACCAGGGTATCTAAT | |
| qRT- | ATTCGCGGTATTGAAGATGC | 189 bp |
| qRT- | AGGCGGTAGGTTTTTCTGCT | |
| qRT- | CCTGAAGGGGTGAATCTCAA | 157 bp |
| qRT- | GCATGTTGTATTTGCGCATC | |
| qRT- | CTCAAACCGTAGCGGTCAAT | 235 bp |
| qRT- | TGTACCAGTTGCGACTCAGC | |
| Primers for EMSA | ||
| EMSA- | ATCGCGTTTTATAACGCTGAT | 200 bp |
| EMSA- | CTAGAAATCATGGCCATAACCA | |
| EMSA- | ATAAAGTCAGCTTGGGATCAAA | 300 bp |
| EMSA- | AGGTGAGATTATTTGCCTTTATTAT | |
| EMSA- | GTCAAAAACGGAAATCCTATCA | 300 bp |
| EMSA- | AGTGGAATTGAAGTCTGAGCAT | |
Underlined letters show Xba I、Sac I、Kpn I、BamH I or XhoI restriction site
F/R: upstream and downstream primers of gene,S/X-F/R: The upstream and downstream primers for the upstream and downstream gene fragments of arcA in the E12382 genome, U/D-F/R: Upstream and downstream sequencing primers of plasmid